» Articles » PMID: 35687814

Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study

Overview
Date 2022 Jun 10
PMID 35687814
Authors
Affiliations
Soon will be listed here.
Abstract

Men who have sex with men (MSM) initiating human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) may increase condomless anal sex (CAS) and number of partners, and, consequently, more often acquire sexually transmitted infections (STIs). Using data from the Amsterdam Cohort Studies, we compared sexual behavior and STI among MSM after PrEP-initiation with controls not initiating PrEP. The MSM reported on sexual behavior and were tested for HIV, chlamydia, gonorrhea, and syphilis semi-annually. We matched MSM who initiated PrEP between January 1, 2015 and December 31, 2019 1:1 to MSM who did not use time-dependent propensity scores based on age, sexual behavior, and STI. Primary end-points were number of casual partners, and proportion with CAS and receptive CAS (rCAS) with casual partners, sexualized drug use (SDU), any STI, and anal STI. We modeled end-points during the 4 years before and 2 years after PrEP-initiation or matched PrEP-initiation timepoint by using logistic regression (dichotomous end-points) or negative binomial regression (count end-point), adjusted for calendar year. Two hundred twenty-eight out of the 858 (26.6%) MSM initiated PrEP. We matched 198 out of 228 (86.8%) to a control. Before PrEP-initiation, end-points increased over time in both groups, with no statistically significant difference. The odds of CAS, rCAS, and anal STI were on average higher after than before PrEP-initiation in PrEP initiators, whereas after versus before differences were not observed in controls. After PrEP-initiation, PrEP initiators had statistically significantly more casual partners, and higher odds of CAS, rCAS, SDU, any STI, and anal STI than controls. These findings support frequent STI screening and counseling in MSM using PrEP.

Citing Articles

Syphilis infection prevalence in the Middle East and North Africa: a systematic review and meta-analysis.

El-Jamal M, Annan B, Al Tawil A, Hamati M, Almukdad S, Fakih I EClinicalMedicine. 2025; 75:102746.

PMID: 39763595 PMC: 11701444. DOI: 10.1016/j.eclinm.2024.102746.


Impact of Varying Pre-exposure Prophylaxis Programs on HIV and Neisseria gonorrhoeae Transmission Among MSM in the Netherlands: A Modeling Study.

Reitsema M, Wallinga J, van Sighem A, Bezemer D, Van Der Valk M, van Aar F J Acquir Immune Defic Syndr. 2024; 97(4):325-333.

PMID: 39172008 PMC: 11500695. DOI: 10.1097/QAI.0000000000003511.


Prevalence and Treatment Outcomes of Syphilis among People with Human Immunodeficiency Virus (HIV) Engaging in High-Risk Sexual Behavior: Real World Data from Northern Greece, 2019-2022.

Nanoudis S, Pilalas D, Tziovanaki T, Constanti M, Markakis K, Pagioulas K Microorganisms. 2024; 12(7).

PMID: 39065024 PMC: 11278651. DOI: 10.3390/microorganisms12071256.


The Best Predictor of Future Behavior May Be the Past: Exploring Behavior Change in Men Who Have Sex with Men Using Pre-exposure Prophylaxis in the Netherlands.

van Wees D, Coyer L, van den Elshout M, de Coul E, van Aar F Arch Sex Behav. 2024; 53(7):2777-2793.

PMID: 38709341 PMC: 11219441. DOI: 10.1007/s10508-024-02863-z.


Doxycycline as Postsexual Exposure Prophylaxis: Use, Acceptability, and Associated Sexual Health Behaviors Among a Multi-Site Sample of Clinical Trial Participants.

Fredericksen R, Perkins R, Brown C, Cannon C, Lopez C, Cohee A AIDS Patient Care STDS. 2024; 38(4):155-167.

PMID: 38656217 PMC: 11236279. DOI: 10.1089/apc.2023.0289.


References
1.
Unemo M, Bradshaw C, Hocking J, de Vries H, Francis S, Mabey D . Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017; 17(8):e235-e279. DOI: 10.1016/S1473-3099(17)30310-9. View

2.
Coyer L, Boyd A, Davidovich U, van Bilsen W, Prins M, Matser A . Increase in recreational drug use between 2008 and 2018: results from a prospective cohort study among HIV-negative men who have sex with men. Addiction. 2021; 117(3):656-665. PMC: 9292014. DOI: 10.1111/add.15666. View

3.
Reitsema M, van Hoek A, Schim van der Loeff M, Hoornenborg E, van Sighem A, Wallinga J . Preexposure prophylaxis for men who have sex with men in the Netherlands: impact on HIV and Neisseria gonorrhoeae transmission and cost-effectiveness. AIDS. 2020; 34(4):621-630. DOI: 10.1097/QAD.0000000000002469. View

4.
OByrne P, Orser L, Haines M . Active-Offer Nurse-Led PrEP (PrEP-RN) Referrals: Analysis of Uptake Rates and Reasons for Declining. AIDS Behav. 2019; 24(5):1281-1289. PMC: 7156352. DOI: 10.1007/s10461-019-02745-9. View

5.
Mounzer K, Fusco J, Hsu R, Brunet L, Vannappagari V, Frost K . Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort. AIDS Patient Care STDS. 2021; 35(11):419-427. DOI: 10.1089/apc.2021.0064. View